Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,387 | -15,134 | -7,992 | -34,101 | -26,687 |
| Depreciation Amortization | 991 | 659 | 331 | 1,351 | 1,022 |
| Other Working Capital | -739 | -1,342 | -1,427 | -4,330 | -3,930 |
| Other Operating Activity | 3,257 | 2,409 | 1,472 | 5,057 | 3,735 |
| Operating Cash Flow | $-18,878 | $-13,408 | $-7,616 | $-32,023 | $-25,860 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 25,737 | 12,823 | 5,807 | 38,426 | 30,164 |
| PPE Investments | -146 | -146 | -37 | -14 | -14 |
| Investing Cash Flow | $25,591 | $12,677 | $5,770 | $38,412 | $30,150 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -604 | -400 | -199 | -761 | -565 |
| Common Stock Repurchased | N/A | N/A | N/A | -10,384 | -10,132 |
| Other Financing Activity | 11 | 11 | -10 | -28 | -45 |
| Financing Cash Flow | $-593 | $-389 | $-209 | $-11,173 | $-10,742 |
| Beginning Cash Position | 13,011 | 13,011 | 13,011 | 17,795 | 17,795 |
| End Cash Position | 19,131 | 11,891 | 10,956 | 13,011 | 11,343 |
| Net Cash Flow | $6,120 | $-1,120 | $-2,055 | $-4,784 | $-6,452 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,878 | -13,408 | -7,616 | -32,023 | -25,860 |
| Capital Expenditure | -146 | -146 | -37 | -180 | -180 |
| Free Cash Flow | -19,024 | -13,554 | -7,653 | -32,203 | -26,040 |